news
Researchers in France and Canada have discovered an epigenetic alteration…
1 February 2018 | By Drug Target Review
Researchers in France and Canada have discovered an epigenetic alteration of a vitamin B12 gene – MMACHC – that has significant implications for our understanding of cblC and other rare diseases.